Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells

被引:20
|
作者
Li, Deguan [1 ,2 ]
Chen, Renxiang [3 ]
Wang, Yi-Wen [3 ]
Fornace, Albert J., Jr. [3 ,4 ]
Li, Heng-Hong [3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China
[2] Peking Union Med Coll, Tianjin, Peoples R China
[3] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA
[4] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
基金
中国国家自然科学基金;
关键词
Programmed cell death protein 1 (PD-1); ionizing radiation; T cells; checkpoint blockade; ANTITUMOR IMMUNITY; UP-REGULATION; RADIATION; CANCER; MICROENVIRONMENT; ACTIVATION; RESISTANCE; RESPONSES; EXPOSURE; OVERCOME;
D O I
10.1080/09553002.2017.1400192
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: In this study we addressed the question whether radiation-induced adverse effects on T cell activation are associated with alterations of T cell checkpoint receptors. Materials and methods: Expression levels of checkpoint receptors on T cell subpopulations were analyzed at multiple post-radiation time points ranging from one to four weeks in mice receiving a single fraction of 1 or 4 Gy of c-ray. T cell activation associated metabolic changes were assessed. Results: Our results showed that prior irradiation resulted in significant elevated expression of programmed cell death protein 1 (PD-1) in both CD4+ and CD8+ populations, at all three post-radiation time points. T cells with elevated PD-1 mostly were either central memory or naive cells. In addition, the feedback induction of PD-1 expression in activated T cells declined after radiation. Conclusion: Taken together, the elevated PD-1 level observed at weeks after radiation exposure is connected to T cell dysfunction. Recent preclinical and clinical studies have showed that a combination of radiotherapy and T cell checkpoint blockade immunotherapy including targeting the programmed death-ligand 1 (PD-L1)/PD-1 axis may potentiate the antitumor response. Understanding the dynamic changes in PD-1 levels in T cells after radiation should help in the development of a more effective therapeutic strategy.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 50 条
  • [31] Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+T Cells Are Expanded in Early Rheumatoid Arthritis and Correlate with Response to Treatment
    Williams, Katie
    Small, Annabelle
    Song, Qingxuan
    Cole, Suzanne
    Hao, Ling-yang
    Murray-Brown, William
    Proudman, Susanna
    Smith, Malcolm
    Nagpal, Sunil
    Wechalekar, Mihir
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3172 - 3172
  • [32] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Kotaro Matsuda
    Hiroaki Miyoshi
    Koji Hiraoka
    Tetsuya Hamada
    Shiro Yoshida
    Yukinao Ishibashi
    Toshiaki Haraguchi
    Naoto Shiba
    Koichi Ohshima
    Clinical and Experimental Medicine, 2018, 18 : 487 - 494
  • [33] Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice
    Xuangjie Guo
    Yiping Xu
    Wei Luo
    Rongli Fang
    Li Cai
    Ping Wang
    Yuxia Zhang
    Zhe Wen
    Yanhui Xu
    BMC Pediatrics, 21
  • [34] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nakamura, S.
    Fujiwara, T.
    Tahara, T.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
  • [35] Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice
    Guo, Xuangjie
    Xu, Yiping
    Luo, Wei
    Fang, Rongli
    Cai, Li
    Wang, Ping
    Zhang, Yuxia
    Wen, Zhe
    Xu, Yanhui
    BMC PEDIATRICS, 2021, 21 (01)
  • [36] PET Imaging of Programmed Cell Death Protein 1 (PD-1) in a Humanized Mouse Model of Lung Cancer
    Cai, W.
    Jiang, D.
    England, C. G.
    Barnhart, T. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S144 - S145
  • [37] Role of programmed cell death protein-1 (PD-1)-targeted immunotherapy in hepatocellular carcinoma.
    Li, Shaohua
    Mei, Jie
    Wang, Qiaoxuan
    Wei, Wei
    Lu, Lianghe
    Zou, Jingwen
    Zhao, Rongce
    Guo, Zhixing
    Ling, Yihong
    Wen, Yuhua
    Lin, Wenping
    Zheng, Lie
    Chen, Minshan
    Guo, Rongping
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population
    Yang, Q.
    Liu, Y.
    Liu, D.
    Zhang, Y.
    Mu, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 13 - 18
  • [39] Outcomes in Patients with Interstitial Lung Disease Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors
    Dobre, I.
    Frank, A. J.
    D'Silva, K. M.
    Okin, D.
    Sharma, A.
    Montesi, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [40] Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience
    Mahn, Robert
    Vogt, Annabelle
    Kupczyk, Patrick
    Sadeghlar, Farsaneh
    van Beekum, Katrin
    Hueneburg, Robert
    Meyer, Carsten
    Toma, Marieta
    Ahmadzadehfar, Hojjat
    Essler, Markus
    Matthaei, Hanno
    Lingohr, Philipp
    Kalff, Joerg C.
    Strassburg, Christian P.
    Gonzalez-Carmona, Maria A.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (09) : 1057 - 1062